General Information of Drug Transporter (DT)
DT ID DTD0332 Transporter Info
Gene Name SLC38A5
Transporter Name Sodium-coupled neutral amino acid transporter 5
Gene ID
92745
UniProt ID
Q8WUX1
Post-Translational Modification of This DT
Overview of SLC38A5 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Acetylation X-N-glycosylation X-Phosphorylation X-Ubiquitination X: Amino Acid

Acetylation

  Methionine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A5 [1]

Role of PTM

Potential impacts

Modified Residue

Methionine

Modified Location

1

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC38A5 Methionine 1 has the potential to affect its expression or activity.

N-glycosylation

  Asparagine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A5 [2]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

226

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC38A5 Asparagine 226 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A5 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

29

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A5 Serine 29 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC38A5 [3] , [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

36

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A5 Serine 36 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC38A5 [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

372

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A5 Serine 372 has the potential to affect its expression or activity.

  Tyrosine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A5 [7] , [8]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

19

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A5 Tyrosine 19 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A5 [9] , [10]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

37

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC38A5 Lysine 37 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC38A5 [9] , [10]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

369

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC38A5 Lysine 369 has the potential to affect its expression or activity.
References
1 N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB. Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12449-54.
2 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S38A5_HUMAN)
3 Offline pentafluorophenyl (PFP)-RP prefractionation as an alternative to high-pH RP for comprehensive LC-MS/MS proteomics and phosphoproteomics. Anal Bioanal Chem. 2017 Jul;409(19):4615-4625.
4 Triomics Analysis of Imatinib-Treated Myeloma Cells Connects Kinase Inhibition to RNA Processing and Decreased Lipid Biosynthesis. Anal Chem. 2015 Nov 3;87(21):10995-1006.
5 Protein kinase C-alpha interaction with F0F1-ATPase promotes F0F1-ATPase activity and reduces energy deficits in injured renal cells. J Biol Chem. 2015 Mar 13;290(11):7054-66.
6 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
7 Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine Profiling. Mol Cell Proteomics. 2016 Aug;15(8):2671-85.
8 Isoelectric point-based fractionation by HiRIEF coupled to LC-MS allows for in-depth quantitative analysis of the phosphoproteome. Sci Rep. 2017 Jul 3;7(1):4513.
9 A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.
10 Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.